General Dermatology Archives

General Dermatology

Cancer Risk Not Associated With Omalizumab Use for Chronic Urticaria, Asthma

By

Colby Stong

January 28, 2022

The risk for cancer in patients who received omalizumab for treatment of chronic urticaria and asthma is assessed.

General Dermatology

Working Core Outcome Set Aims to Improve Cutaneous Lupus Erythematosus Clinical Trials

By

Inga Back, MPH

January 27, 2022

Researchers developed a working core outcome set with the objective of improving clinical studies in cutaneous lupus erythematosus.

General Medicine

The Most Frequent Cutaneous Manifestation After COVID-19 Vaccination

By

Colby Stong

January 20, 2022

Cutaneous manifestations after COVID-19 vaccination are recorded and reported by researchers.

Papulopustular acne (acne with papules and pustules) on the face of a female.

General Dermatology

Insight Into Pathogenesis of Postinflammatory Hyperpigmentation, Erythema

By

Dermatology Advisor Contributing Writer

January 20, 2022

Mechanisms of postinflammatory hyperpigmentation (PIH) and postinflammatory erythema (PIE) may be closer to being identified.

Lichen planus (LP) is a chronic, inflammatory, papulosquamous, autoimmune disease that is estimated to occur in <1% of the general population.1 It appears to be more common in individuals with HCV, with 1 study reporting a 4.80 times higher prevalence in this population.4 LP can affect the skin, scalp, genitals, oral cavity and other mucus membranes, and nails. Its etiology is not well understood, but genetic, environmental, and lifestyle factors are thought to play a role. An immune mechanism directed by activated CD81 T cells against basal keratinocytes has been suggested to play a major role in the pathophysiology of the disease, with cytokines such as tumor necrosis factor-α, interferon-γ, and interleukin-6 and interleukin-8 thought to contribute in the setting of HCV infection.1 Cutaneous LP is a self-limited disease that usually resolves within 6 to 12 months and mainly affects adults. Photo Credit: ISM/CID.

General Dermatology

Antioxidants as an Adjunctive Treatment for Lichen Planus

By

Estie Mermelstein, MSN, FNP-BC

January 18, 2022

A prospective, case-control study examines the effectiveness of antioxidants in treating lichen planus.

Bald spot on the scalp of a child due to alopecia areata.

General Dermatology

QR678 Neo® Effective for Alopecia Areata in Adults vs Corticosteroid Therapy

By

Estie Mermelstein, MSN, FNP-BC

January 13, 2022

Researchers aimed to compare the efficacy of QR678 Neo® plus intralesional steroid therapy vs intralesional steroid therapy alone for alopecia areata.

General Dermatology

Novel Itraconazole Dose for Tinea Capitis in Children

By

Estie Mermelstein, MSN, FNP-BC

January 6, 2022

Treatment of tinea capitis in children with a novel dose of itraconazole is reported.

General Dermatology

Phase 2 STELABEC Trial Supports Ustekinumab for the Treatment of Behçet Disease

By

Emily Pond

January 6, 2022

The safety and efficacy of ustekinumab was determined in a phase 2 trial for the treatment of recurrent oral ulcers in Behçet disease.

General Dermatology

Prevalence Estimates for Diagnosed, Undiagnosed Vitiligo in the US

By

Emily Pond

December 30, 2021

The National Institute for Health and Care Excellence (NICE) provides updated recommendations for managing acne, including both the physical manifestations of the disease as well as its psychological affect.

General Dermatology

Colorimeter Detects Change in Vitiligo Lesions After 1 Month of Nb-UVB Treatment

By

Colby Stong

December 28, 2021

Colorimeter and point counting technique as objective methods for monitoring changes in vitiligo lesions during treatment with Nb-UVB are assessed.